Table 2.
Number of participants with clonal or multiple infections
| February | March | April | May | |||||
|---|---|---|---|---|---|---|---|---|
| No. of clones | Obom | Abura | Obom | Abura | Obom | Abura | Obom | Abura |
| 0a | 20 | 56 | 27 | 55 | 29 | 40 | 34 | 30 |
| 1 | 18 | 6 | 19 | 4 | 11 | 12 | 20 | 23 |
| 2 | 26 | 2 | 9 | 0 | 14 | 2 | 5 | 2 |
| 3 | 10 | 1 | 5 | 0 | 5 | 0 | 3 | 0 |
| 4 | 1 | 0 | 2 | 0 | 1 | 0 | 0 | 0 |
| Total | 75 | 65 | 62 | 59 | 60 | 54 | 62 | 55 |
aNo PCR product was obtained after a repeat genotyping PCR. Children from whom no PCR product was obtained represent healthy children as opposed to asymptomatic children whose samples yielded PCR products